Skip to content

    Vilas Transcore

    VILAS
    Capital Goods·22 May 2025
    Management Summary

    Vilas Transcore reported strong financial performance for H2 and full year FY25, driven by significant capacity expansion and new product introductions. Despite facing project delays, the company is on track for commercial operations of its new facility by July 2025, targeting substantial revenue growth and improved margins from diversified offerings. Management remains net debt-free and projects a normalized tax rate for FY26.

    Highlights

    9
    • H2 FY25 total income stood at INR195 crores, reflecting a 27% year-over-year increase.

    • H2 FY25 EBITDA (including other income) was INR31 crores, up 70% YoY, with a margin of 15.7%.

    • H2 FY25 PAT stood at INR20 crores, up 67% YoY, with a margin of 10.2%.

    • Full year FY25 total income stood at INR362 crores, reflecting a 15% year-over-year increase.

    • Full year FY25 EBITDA (including other income) was INR54 crores, up 55% YoY, with a 14.8% margin.

    • Full year FY25 PAT stood at INR34 crores, up 48% YoY, with a 9.4% margin.

    • Successfully expanded total installed capacity from 12,000 MTPA to 36,000 MTPA.

    • Introduced two new product offerings: transformer radiators and nanocrystalline cores.

    • Remained net debt-free, maintaining a healthy and conservative balance sheet structure.

    Concerns

    4
    • Experienced delays in capacity expansion due to multiple statutory approvals, unforeseen flooding, and shortage of labor/skilled workers.

    • CRGO prices were down 2% this period.

    • Higher receivables and inventory due to increased sales and new plant setup.

    • Effective tax rate for FY25 was 30% due to IPO expenses not being fully deductible.

    What Changed1

    vs Q2 FY26

    Guidance items13 → 19 (+6)
    Key financials

    Metrics

    13

    Periods

    2

    H2 FY25

    5
    • Total Income
      ₹195 Cr
      YoY+27%
    • EBITDA
      ₹31 Cr
      YoY+70%
    • EBITDA Margin
      15.7%
    • PAT
      ₹20 Cr
      YoY+67%
    • PAT Margin
      10.2%

    FY25

    8
    • Total Income
      ₹362 Cr
      YoY+15%
    • EBITDA
      ₹54 Cr
      YoY+55.0%
    • EBITDA Margin
      14.8%
    • PAT
      ₹34 Cr
      YoY+48%
    • PAT Margin
      9.4%

    Order Book

    medium confidence

    Execution

    CRGO orders typically have 2-4 month lead times, with 45-60 days in hand. Amorphous Core has 2-3 months order book.

    "The company operates with a short-term, rolling order book for CRGO laminations (45-60 days in hand) and a 2-3 month order book for Amorphous Cores, indicating consistent demand and execution."

    Source:
    Q&A

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹50 crores this quarter · ₹90 crores (FY25) planned

    From IPO fund and internal accruals

    Debt

    Net ₹0 crores · 0.0x EBITDA

    Liquidity

    Liquidity disclosed

    Other income of INR9 crores from funds lying in the bank in FY25. Management expects INR4-5 crores interest annually from company funds. Anticipates needing INR20-50 crores additional working capital if market slows, but not in current scenario.

    Guidance & targets

    19
    CategoryTargetPriority
    Capacity
    Total Installed Capacity
    36,000 MTPA
    High
    Operations
    Commercial Operation of New Plant
    July 2025
    High
    Capacity Utilization
    New Capacity Utilization
    50%
    High
    Volume
    CRGO Production (New Plant)
    12,000 metric tons
    High
    Volume
    Radiator Production
    300 metric tons per month
    High
    Revenue
    Nanocrystalline Core Revenue
    INR50 crores
    High
    Revenue
    Radiator Revenue
    INR35-36 crores
    High
    Revenue
    Total Turnover
    INR600 crores
    High
    Revenue
    Total Turnover
    INR1,000 crores
    High
    Market Share
    CRGO Market Share
    5-6%
    High
    Profitability
    Nanocrystalline Core EBITDA Margin
    25%
    High
    Profitability
    Radiator EBITDA Margin
    20-22%
    High
    Profitability
    CRGO Net Margin (Base)
    7%
    High
    Profitability
    Blended EBITDA Margin
    12-14%
    Medium
    Tax
    Effective Tax Rate
    25%
    High
    Approvals
    PGCIL Approval for Higher kV
    6-7 months from July 2025
    Medium
    Depreciation
    Additional Depreciation (New Plant)
    INR4-5 crores
    High
    Efficiency
    Asset Turnover (New Expansion)
    10x
    High
    Exports
    Export Percentage of Sales
    5-10%
    Medium

    New Plant Commercial Operations

    next quarter
    CurrentTrial production to commence in 10-15 days
    TargetFull-scale commercial operation by July 2025

    Why it matters

    This is the key trigger for revenue growth from the expanded capacity and new products.

    Today, I'm pleased to report that all the machineries are at the final stage of installation. Trial production will commence in the next 10 to 15 days. We are on track to begin full-scale commercial operation by July 2025.

    How to verify

    detailed_narrative[title='Capacity Expansion & Diversification']

    Risks & concerns

    4
    RiskSeverity

    Project Execution Delays

    Delays in capacity expansion due to multiple statutory approvals, unforeseen flooding, and shortage of labor/skilled workers.Management acknowledged

    medium

    Raw Material Price Volatility (CRGO)

    CRGO prices were down 2% this period, but management aims to maintain pricing through market study and strategy.Management acknowledged

    medium

    Working Capital Management

    Increase in receivables (2 months outstanding) and inventory (1,000-1,500 MT for new plant) due to strong sales and strategic build-up.Analyst acknowledged

    low

    Competition from China

    Potential impact from Chinese BIS-approved material, but management is confident in quality and delivery, not seeing significant low-cost supply yet.Management acknowledged

    medium

    Q&A highlights

    8

    “As we said, we have put the plant of 700 metric tons per month, 600 metric tons -so and next - - this financial year, we are targeting to reach to around 300 metric tons per month as in radiator and the lamination is 1,000 metric tons per month. So 12,000 metric tons and 3,600 metric tons for radiator, and 12,000 metric tons for the CRGO is targeted for this financial year. ... That we will contribute in somewhere around INR50 crores as a value, because that is -- what we described in our tones because the few sales are in the Pieces and sales cells are in kgs.”

    Clarifies the expected volume and revenue contribution from new products (radiators, nanocrystalline cores) and CRGO from the new capacity for FY26.

    asked by Naman Parmar

    3 min read7 chapters

    Detailed Narrative

    01

    Capacity Expansion & Diversification

    Vilas Transcore successfully expanded its total installed capacity from 12,000 metric tons per annum (MTPA) to 36,000 MTPA, a significant 200% increase. This expansion is aligned with the company's long-term strategy to meet growing demand and improve operational efficiencies. The company also diversified its product portfolio by introducing transformer radiators with an installed capacity of 7,200 MTPA and nanocrystalline cores, with commercial operations for the new plant expected to begin by July 2025.

    02

    Strong Financial Performance in H2 & FY25

    For H2 FY25, total income grew 27% year-over-year to INR195 crores, with EBITDA (including other income) rising 70% to INR31 crores, achieving a 15.7% margin. Profit after tax (PAT) for the half-year increased 67% to INR20 crores, with a 10.2% PAT margin. For the full year FY25, total income was INR362 crores (up 15% YoY), EBITDA was INR54 crores (up 55% YoY) with a 14.8% margin, and PAT was INR34 crores (up 48% YoY) with a 9.4% margin. The company also reported strong return ratios with ROE at 16.4% and ROCE at 17.7%.

    03

    New Product Offerings and Margin Profile

    The company introduced transformer radiators and nanocrystalline cores. Radiators, critical for heat distribution in transformers, are targeted to contribute INR35-36 crores in revenue for FY26 with a 20-22% EBITDA margin. Nanocrystalline cores, used in advanced applications like EV chargers, are expected to contribute INR50 crores in revenue for FY26 with a higher gross/EBITDA margin of approximately 25%. These new products are expected to enhance the value-added product mix and contribute meaningfully to revenue growth and overall company margins.

    04

    Operational Challenges and Resilience

    The journey to capacity expansion faced challenges including delays due to multiple statutory approvals, unforeseen flooding at the project site, and a shortage of labor and skilled workers. Despite these setbacks, the company demonstrated resilience, with all machinery now in the final stage of installation and trial production imminent. Management expressed confidence in achieving full capacity utilization on the existing 12,000 MTPA capacity in FY25, producing 12,069 MT.

    05

    Market Outlook & Raw Material Dynamics

    Management noted strong and sustained customer demand, with the company well-positioned to meet rising demand in both domestic and international markets. The CRGO market saw pricing fluctuations, with a 2% decrease this period. The company maintains a 60% local and 40% imported raw material sourcing mix, with imported materials generally being lower priced. Despite some market panic regarding Chinese BIS-approved material, management has maintained its pricing strategy, focusing on quality and delivery.

    06

    Capital Expenditure and Funding

    The total capital expenditure for the expansion was approximately INR90 crores, with INR50 crores spent by March 31, 2025, and the remaining to be spent in Q1 FY26. Of this, INR40 crores was directly invested in expansion, with INR7.5 crores for IPO expenses and INR2.5 crores for other corporate expenses. The company remains net debt-free, maintaining a healthy and conservative balance sheet structure. Management anticipates an asset turnover of 10x for the new expansion, indicating high capital efficiency.

    07

    Future Growth and PGCIL Approvals

    Vilas Transcore aims for INR600 crores turnover in FY26 and INR1,000 crores in FY27, targeting a CRGO market share of 5-6% from the current 3%. The company plans to apply for PGCIL approval for higher kV products (220kV, 400kV, 765kV) starting July 2025, with approval expected in 6-7 months. This will enable them to cater to a broader range of power transformer manufacturers. The blended EBITDA margin is projected to be 12-14% for FY27, and the effective tax rate is expected to normalize📎 to 25% in FY26.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.